International
Aiforia obtained the In Vitro Diagnostic Regulation (IVDR) certification and successfully launches three new CE-IVD marked AI solutions for breast and prostate cancer diagnostics Aiforia Technologies Plc, Press Release, February 20, 2025 at...
Why clearer, more actionable reports could drive wider AI adoption in diagnostics If you had asked Flora Abilova 20 years ago where she saw herself, she might have pictured a courtroom, arguing cases with the sharp precision of a seasoned...
WILMINGTON, Mass. and DUBLIN, Ireland—February 10, 2025—Charles River Laboratories International, Inc. (NYSE: CRL) and Deciphex, a leader in AI-powered digital pathology, today announced the next phase of a strategic collaboration to focus...
Learn how Tribun Health and Ibex are integrating AI-powered digital pathology to improve diagnoses, streamline workflows, and support pathologists globally. Artificial intelligence is gradually becoming a practical tool for healthcare,...
Nijmegen, the Netherlands – Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has announced the latest advancement in its automated quality control (QC)...
Nijmegen, the Netherlands – Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, is thrilled to announce the integration of its NephroPath AI tools into HistoWiz’s PathologyMap™ platform....
